KRRO vs RJF · $159.8M cap vs rev $15.91B
Korro Bio, Inc. (KRRO) versus RJF (RJF) — a side-by-side from cached financials, not a winner call.
Korro Bio, Inc. (KRRO) is a biotechnology company listed on US.
RJF (RJF) common stock.
Latest reported KRRO revenue for 2026-06-30 was $0. Net income was -$38.5M. KRRO currently screens at market cap $159.8M.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
KRRO currently screens at market cap $159.8M. RJF currently screens at market cap $0.
Not investment advice. Open the KRRO and RJF stock pages for the full models.
Not investment advice.